Dr. Magued F. Beshay, MD

Dr. Beshay practices at Facey Endoscopy Center in Mission Hills, California.

Dr. Beshay's NPI, 1538275938, was assigned on August 21, 2006. Dr. Beshay graduated from University of Alexandria Faculty of Medicine in 1980. Dr. Beshay holds California license A45609.

Dr. Beshay's primary practice is Facey Endoscopy Center, at 11333 Sepulveda Blvd, #3200, Mission Hills, CA 91345. The practice phone is (818) 837-5776.

Dr. Beshay's primary practice is Facey Endoscopy Center in Mission Hills, California. Dr. Beshay is also affiliated with Providence Holy Cross Medical Center. The medical group on file is Facey Medical Group. Dr. Beshay's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beshay practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Beshay's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Beshay is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Beshay's licenses on file in 2 states: California and Illinois.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding, hepatitis c and intestinal diverticulosis among the conditions Dr. Beshay treats.

CMS data shows 655 Medicare services from Dr. Beshay across 14 procedure codes in 2024, for 257 Medicare patients. Medicare paid $55,550 for them.

CMS counts 257 Medicare patients who saw Dr. Beshay in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beshay's median patient age at 66, with 53% women.

In 2024, Dr. Beshay wrote 1,783 Medicare Part D claims for 910 patients. 90% of them were for generic drugs. CMS names the drug for 1,721 of them, across 29 drugs with 11 or more claims each, at $116,457 in total drug cost. In 2023, CMS named 1,724 claims across 24 drugs.

Dr. Beshay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 139 procedures of colonoscopy by Dr. Beshay, more than 87% of the clinicians it reports for that procedure.

Dmand AI links Dr. Beshay to 1 clinical trial. Conditions studied include Crohn Disease and Inflammatory Bowel Diseases. Open Payments lists research payments to Dr. Beshay that name 1 trial.

CMS Open Payments shows 541 general payments to Dr. Beshay from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $4,936. It also lists 2 research payments totaling $890 from 2016 to 2017, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Beshay, most recently AGA Fellow in 2011.

Dr. Beshay graduated from University of Alexandria Faculty of Medicine in 1980. Dr. Beshay is a member of ACG, AGA and ASGE.

Dr. Beshay is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.